Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00898235 · ClinicalTrials.gov registry record
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
A clinical trial of Multiple Myeloma, sponsored by Boston Medical Center.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 1
- Study location
NCT00898235: Recruiting study of Multiple Myeloma, sponsored by Boston Medical Center.
NCT00898235 is a study of Multiple Myeloma that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 10,000 participants, above the 524-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1808% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00898235, a study of Multiple Myeloma, is actively recruiting participants, sponsored by Boston Medical Center.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 1
- Study location
Study Summary
RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future. PURPOSE: This research study is collecting samples from patients with amyloid diseases
Conditions Studied
Interventions
- OTHER biologic sample preservation procedure
- OTHER laboratory biomarker analysis
- GENETIC clonality analysis
- GENETIC polymerase chain reaction
- GENETIC protein analysis
Study Locations (1)
Massachusetts
- Boston University Cancer Research Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2000-01 |
| Est. Completion | 2040-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00898235
The ClinicalTrials.gov registry entry for NCT00898235 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 524-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (1808% higher). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 5 interventions - of which biologic sample preservation procedure is the first listed.
NCT00898235 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00898235 about?
NCT00898235 is a clinical study titled "Collection of Samples and Clinical Data From Patients With Amyloid Diseases". RATIONALE: Collecting and storing samples of blood, urine, tissue and data from patients with amyloid diseases to test in the laboratory may help the study of this disease in the future. PURPOSE: This research study is collecting samples from patients with amyloid diseases
What is the current status of trial NCT00898235?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2000-01. Estimated completion is 2040-12.
What conditions does trial NCT00898235 study?
This clinical trial studies the following conditions: Multiple Myeloma.
What interventions are being tested in trial NCT00898235?
The interventions under investigation include: biologic sample preservation procedure (OTHER), laboratory biomarker analysis (OTHER), clonality analysis (GENETIC), polymerase chain reaction (GENETIC), protein analysis (GENETIC).
Who is sponsoring clinical trial NCT00898235?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00898235 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Multiple Myeloma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
A Study of Whether Ide-cel (bb2121) Can Be Made From People With Multiple Myeloma Who Have Had a Hematopoietic Cell Transplant
RECRUITING · Phase 2
-
A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments
RECRUITING · Phase 1
-
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
RECRUITING · NA
-
Development of a Research Infrastructure for Understanding and Addressing Multiple Myeloma Disparities
RECRUITING
-
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.